Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Cryptotanshinone mitigates ischemia reperfusion-induced testicular damage: A experimental study

Ayhan Tanyeli, Ersen Eraslan, Fazile Nur Ekinci Akdemir, Mustafa Can Guler, Derya Guzel Erdogan, Elif Polat, Omer Topdagi.




Abstract
Cited by 6 Articles

Aim: The aim of this study is to investigate the protective effects of cryptotanshinone on ischemia reperfusion-induced testis damage.
Materials and Methods: In this study, the rats were divided into 3 groups. Groups of the study are planned as follows; sham, ischemia reperfusion, and ischemia reperfusion+cryptotanshinone. Oxidant molecules such as total oxidant status (TOS), malondialdehyde (MDA), myeloperoxidase (MPO) and antioxidant molecules like total antioxidant status (TAS), superoxide dismutase (SOD) with oxidative stress index (OSI) were evaluated in the testicular tissues obtained at the end of the experiment.
Results: In ischemia reperfusion group, TAS and SOD levels decreased while other oxidant parameters were increased. But in ischemia reperfusion+cryptotanshinone group, the levels of anti¬oxidant parameters increased while the levels of oxidant parameters decreased.
Conclusion: These results have shown us that cryptotanshinone is highly effective against oxidative testis damage caused by ischemia reperfusion.

Key words: Testicular ischemia reperfusion; cryptotanshinone; oxidative stress; inflammation; rat.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.